Okazawa Yu, Mizukoshi Kosuke, Koyama Yu, Okubo Shoki, Komiyama Hiromitsu, Kojima Yutaka, Goto Michitoshi, Habu Sonoko, Hino Okio, Sakamoto Kazuhiro, Orimo Akira
Department of Coloproctological Surgery, Juntendo University Faculty of Medicine; Department of Molecular Pathogenesis, Juntendo University Faculty of Medicine.
Department of Molecular Pathogenesis, Juntendo University Faculty of Medicine; Department of Oral Pathobiological Science and Surgery, Tokyo Dental College.
J Vis Exp. 2018 Jun 14(136):57374. doi: 10.3791/57374.
Despite current advances in human colorectal cancer (CRC) treatment, few radical therapies are effective for the late stages of CRC. To overcome this clinical challenge, tumor xenograft mouse models using long-established human carcinoma cell lines and many transgenic mouse models with tumors have been developed as preclinical models. They partially mimic the features of human carcinomas, but often fail to recapitulate the key aspects of human malignancies including invasion and metastasis. Thus, alternative models that better represent the malignant progression in human CRC have long been awaited. We herein show generation of patient-derived tumor xenografts (PDXs) by subcutaneous implantation of small CRC fragments surgically dissected from a patient. The colon PDXs develop and histopathologically resemble the CRC in the patient. However, few spontaneous micrometastases are detectable in conventional cross-sections of affected distant organs in the PDX model. To facilitate the detection of metastatic dissemination into distant organs, we extracted the tumor organoid cells from the colon PDXs in culture and infected them with GFP lentivirus prior to injection into highly immunodeficient NOD/Shi-scid IL2Rγ (NOG) mice. Orthotopically injected PDX-derived CRC organoid cells consistently form primary tumors positive for GFP in recipient mice. Moreover, spontaneously developing micrometastatic colonies expressing GFP are notably detected in the lungs of these mice by fluorescence microscopy. Moreover, intrasplenic injection of CRC organoids frequently produces hepatic colonization. Taken together, these findings indicate GFP-labelled PDX-derived CRC organoid cells to be visually detectable during a multistep process termed the invasion-metastasis cascade. The described protocols include the establishment of PDXs of human CRC and 3D culture of the corresponding CRC organoid cells transduced by GFP lentiviral particles.
尽管目前人类结直肠癌(CRC)治疗取得了进展,但很少有根治性疗法对晚期CRC有效。为了克服这一临床挑战,已开发出使用长期建立的人类癌细胞系的肿瘤异种移植小鼠模型以及许多患有肿瘤的转基因小鼠模型作为临床前模型。它们部分模拟了人类癌症的特征,但常常无法重现人类恶性肿瘤的关键方面,包括侵袭和转移。因此,长期以来一直期待能有更好地代表人类CRC恶性进展的替代模型。我们在此展示了通过皮下植入从患者手术切除的小CRC片段来生成患者来源的肿瘤异种移植(PDX)。结肠PDX生长并在组织病理学上与患者的CRC相似。然而,在PDX模型中,在受影响的远处器官的常规切片中几乎检测不到自发的微转移。为了便于检测向远处器官的转移扩散,我们从培养的结肠PDX中提取肿瘤类器官细胞,并用GFP慢病毒感染它们,然后再注射到高度免疫缺陷的NOD/Shi-scid IL2Rγ(NOG)小鼠体内。原位注射PDX来源的CRC类器官细胞在受体小鼠中始终形成GFP阳性的原发性肿瘤。此外,通过荧光显微镜在这些小鼠的肺部明显检测到表达GFP的自发形成的微转移菌落。此外,脾内注射CRC类器官经常会导致肝脏定植。综上所述,这些发现表明GFP标记的PDX来源的CRC类器官细胞在一个称为侵袭-转移级联的多步骤过程中是可视可检测的。所描述的方案包括建立人类CRC的PDX以及用GFP慢病毒颗粒转导的相应CRC类器官细胞的3D培养。